353 related articles for article (PubMed ID: 28742207)
41. PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway.
Bi J; Sun K; Wu H; Chen X; Tang H; Mao J
Biochem Biophys Res Commun; 2018 Apr; 498(4):1037-1044. PubMed ID: 29550470
[TBL] [Abstract][Full Text] [Related]
42. Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.
Jing Y; Wu M; Zhang D; Chen D; Yang M; Mei S; He L; Gu J; Qi N; Fu L; Li L; Mei C
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F479-F486. PubMed ID: 29513074
[TBL] [Abstract][Full Text] [Related]
43. Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway.
Li JL; Liu XL; Guo SF; Yang Y; Zhu YL; Li JZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9238-9250. PubMed ID: 31773675
[TBL] [Abstract][Full Text] [Related]
44. MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
Dai H; Wang C; Yu Z; He D; Yu K; Liu Y; Wang S
Cancer Biother Radiopharm; 2018 Apr; 33(3):103-109. PubMed ID: 29641255
[TBL] [Abstract][Full Text] [Related]
45. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
46. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
[TBL] [Abstract][Full Text] [Related]
47. Promoter methylation and expression of SOCS3 affect the clinical outcome of pediatric acute lymphoblastic leukemia by JAK/STAT pathway.
Liu K; Wu Z; Chu J; Yang L; Wang N
Biomed Pharmacother; 2019 Jul; 115():108913. PubMed ID: 31054507
[TBL] [Abstract][Full Text] [Related]
48. Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.
La Manna S; Lee E; Ouzounova M; Di Natale C; Novellino E; Merlino A; Korkaya H; Marasco D
Int J Cancer; 2018 Nov; 143(9):2177-2186. PubMed ID: 29752723
[TBL] [Abstract][Full Text] [Related]
49. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
Int Immunopharmacol; 2017 Aug; 49():203-211. PubMed ID: 28601022
[TBL] [Abstract][Full Text] [Related]
50. [Interferon-β combined with all-trans retinoic acid supresses proliferation and promote apoptosis by inhibiting JAK2/STAT3 pathway in HepG2 human hepatocellular carcinoma cells].
Zhao J; Nie W; Li W; Zhou X; Sun H; Zhu J; Chen J; Peng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):901-5. PubMed ID: 27363269
[TBL] [Abstract][Full Text] [Related]
51. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway.
Hu J; Chen K; Hong F; Gao G; Dai X; Yin H
Cancer Gene Ther; 2024 Feb; 31(2):228-236. PubMed ID: 38030810
[TBL] [Abstract][Full Text] [Related]
52. [Proliferation apoptotic influence of crocin on human bladder cancer T24 cell line].
Zhao P; Luo CL; Wu XH; Hu HB; Lv CF; Ji HY
Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(15):1869-73. PubMed ID: 19007019
[TBL] [Abstract][Full Text] [Related]
53. SOCS3 Silencing Promotes Activation of Vocal Fold Fibroblasts via JAK2/STAT3 Signaling Pathway.
Li X; Hu R; Wang H; Xu W
Inflammation; 2023 Aug; 46(4):1318-1331. PubMed ID: 37154979
[TBL] [Abstract][Full Text] [Related]
54. [Effects of selective cyclooxygenase-2 inhibitor on proliferation and apoptosis of human bladder cancer cell line T24].
Zhang J; Xu ZQ; Hu Q; Qiu XW; Wang ZR
Ai Zheng; 2007 Apr; 26(4):377-81. PubMed ID: 17430655
[TBL] [Abstract][Full Text] [Related]
55. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3.
Shen A; Chen Y; Hong F; Lin J; Wei L; Hong Z; Sferra TJ; Peng J
Oncol Rep; 2012 Dec; 28(6):2125-30. PubMed ID: 23027374
[TBL] [Abstract][Full Text] [Related]
56. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
Smolensky D; Rathore K; Cekanova M
BMC Cancer; 2015 Nov; 15():927. PubMed ID: 26597249
[TBL] [Abstract][Full Text] [Related]
57. STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
Tsujita Y; Horiguchi A; Tasaki S; Isono M; Asano T; Ito K; Asano T; Mayumi Y; Kushibiki T
Oncol Rep; 2017 Oct; 38(4):2197-2204. PubMed ID: 28849140
[TBL] [Abstract][Full Text] [Related]
58. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
59. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
[TBL] [Abstract][Full Text] [Related]
60. CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells.
Mo M; Zhou M; Wang L; Qi L; Zhou K; Liu LF; Chen Z; Zu XB
PLoS One; 2015; 10(3):e0119506. PubMed ID: 25798926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]